Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrating Artificial Intelligence for Drug Discovery in the Context of Revolutionizing Drug Delivery
Anita Ioana Visan, Irina Neguț
Life (2024) Vol. 14, Iss. 2, pp. 233-233
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Advances in artificial intelligence for drug delivery and development: A comprehensive review
Amol D. Gholap, Md Jasim Uddin, Md. Faiyazuddin, et al.
Computers in Biology and Medicine (2024) Vol. 178, pp. 108702-108702
Closed Access | Times Cited: 17
Dental biomaterials redefined: molecular docking and dynamics-driven dental resin composite optimization
Ravinder Saini, Rayan Ibrahim H. Binduhayyim, Vishwanath Gurumurthy, et al.
BMC Oral Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 11
Farmasi Cerdas: Era Baru Penemuan Obat dengan AI dan Big Data
Raymond R. Tjandrawinata
MEDICINUS (2025) Vol. 38, Iss. 1, pp. 27-36
Closed Access
Future of Artificial Intelligence (AI) - Machine Learning (ML) Trends in Pathology and Medicine
Matthew G. Hanna, Liron Pantanowitz, Rajesh Dash, et al.
Modern Pathology (2025), pp. 100705-100705
Open Access
Drug repositioning for Parkinson’s disease: an emphasis on artificial intelligence approaches
Iman Karimi-Sani, Mehrdad Sharifi, Nahid Abolpour, et al.
Ageing Research Reviews (2025) Vol. 104, pp. 102651-102651
Closed Access
AI-driven antimicrobial peptides for drug development
Y. K. Arora, H. B. Lalwani, Ajay Kumar, et al.
Methods in microbiology (2025)
Closed Access
AI-powered drug discovery for neglected diseases: accelerating public health solutions in the developing world
MD Nahid Hassan Nishan
Journal of Global Health (2025) Vol. 15
Open Access
Artificial intelligence driven innovations in biochemistry: A review of emerging research frontiers
Mohammed Abdul Lateef Junaid
Biomolecules and Biomedicine (2025)
Open Access
Trends in Drug Repurposing: Advancing Cardiovascular Disease Management in Geriatric Populations
Murali Krishna Moka, Melvin George, Deepalaxmi Rathakrishnan, et al.
Current Research in Translational Medicine (2025) Vol. 73, Iss. 2, pp. 103496-103496
Closed Access
Integrating AI into Cancer Immunotherapy—A Narrative Review of Current Applications and Future Directions
David B. Olawade, Aanuoluwapo Clement David-Olawade, Temitope Adereni, et al.
Diseases (2025) Vol. 13, Iss. 1, pp. 24-24
Open Access
Advances in the structural performance of reinforced concrete flat plate-column connections under gravity and seismic loads
Abathar M. Al-Yaseri, Laith Kh. Al-Hadithy
Journal of Building Pathology and Rehabilitation (2025) Vol. 10, Iss. 1
Closed Access
Artificial Intelligence, Computational Tools and Robotics for Drug Discovery, Development, and Delivery
Ayodele James Oyejide, Yemi A. Adekunle, Oluwatosin David Abodunrin, et al.
Intelligent Pharmacy (2025)
Open Access
Foundations and Emerging Trends in Generative Artificial Intelligence (AI) for Industrial Applications
Narasimha Rao Vajjhala, Sanjiban Sekhar Roy, Burak Taşçı, et al.
(2025), pp. 1-18
Closed Access
Two heads are better than one: Unravelling the potential Impact of Artificial Intelligence in nanotechnology
Gaurav Gopal Naik, Vijay A. Jagtap
Nano TransMed (2024) Vol. 3, pp. 100041-100041
Open Access | Times Cited: 5
A Chronicle Review of In-Silico Approaches for Discovering Novel Antimicrobial Agents to Combat Antimicrobial Resistance
Nagarjuna Prakash Dalbanjan, S. K. Praveen Kumar
Indian Journal of Microbiology (2024) Vol. 64, Iss. 3, pp. 879-893
Closed Access | Times Cited: 5
Artificial Intelligence in nanotechnology for treatment of diseases
Soroush Heydari, Niloofar Masoumi, Erfan Esmaeeli, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 10, pp. 1247-1266
Closed Access | Times Cited: 5
Artificial Intelligence in Head and Neck Cancer: Innovations, Applications, and Future Directions
Tuan D. Pham, Muy‐Teck Teh, Domniki Chatzopoulou, et al.
Current Oncology (2024) Vol. 31, Iss. 9, pp. 5255-5290
Open Access | Times Cited: 4
The Artificial Intelligence-Driven Pharmaceutical Industry: A Paradigm Shift in Drug Discovery, Formulation Development, Manufacturing, Quality Control, and Post-Market Surveillance
Kampanart Huanbutta, Kanokporn Burapapadh, Pakorn Kraisit, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 203, pp. 106938-106938
Open Access | Times Cited: 4
The Applications of Artificial Intelligence (AI)-Driven Tools in Virus-Like Particles (VLPs) Research
Bugude Laxmi, P. Uma Maheswari Devi, Naveen Thanjavur, et al.
Current Microbiology (2024) Vol. 81, Iss. 8
Closed Access | Times Cited: 3
Harnessing artificial intelligence for predictive modelling in oral oncology: Opportunities, challenges, and clinical Perspectives
Vishnu Priya Veeraraghavan, Shikhar Daniel, Arun Kumar Dasari, et al.
Oral Oncology Reports (2024) Vol. 11, pp. 100591-100591
Open Access | Times Cited: 3
Artificial intelligence as a tool in drug discovery and development
Maria Kokudeva, Mincho Vichev, Emilia Naseva, et al.
World Journal of Experimental Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 3
AI-Driven Innovations in Alzheimer's Disease: Integrating Early Diagnosis, Personalized Treatment, and Prognostic Modelling
Mayur B. Kale, Nitu L. Wankhede, Rupali S. Pawar, et al.
Ageing Research Reviews (2024), pp. 102497-102497
Closed Access | Times Cited: 3
Rewriting the textbook for pharma: how to adapt and thrive in a digital, personalized and collaborative world
Charles H. Jones, Subha Madhavan, Natarajan Kannan, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 9, pp. 104112-104112
Open Access | Times Cited: 2
Future Perspective: Harnessing the Power of Artificial Intelligence in the Generation of New Peptide Drugs
Nour Nissan, M. C. ALLEN, David A. Sabatino, et al.
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1303-1303
Open Access | Times Cited: 2
Perspectives, Challenges, and the Future of Biomedical Technology and Artificial Intelligence
Saúl Tovar‐Arriaga, Gerardo I. Pérez‐Soto, Karla A. Camarillo‐Gómez, et al.
Technologies (2024) Vol. 12, Iss. 11, pp. 212-212
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top